Publications of Marcus Ising
All genres
Journal Article (290)
1.
Journal Article
Development of a Genetic Test Indicating Increased AVP/V1b Signalling in Patients with Acute Depression. PHARMACOPSYCHIATRY (2025)
2.
Journal Article
14 (3), e074925 (2024)
Cohort profile: BioMD-Y (biopsychosocial factors of major depression in youth) - a biobank study on the molecular genetics and environmental factors of depression in children and adolescents in Munich. BMJ OPEN 3.
Journal Article
14, 1161097 (2023)
The associations of Positive and Negative Valence Systems, Cognitive Systems and Social Processes on disease severity in anxiety and depressive disorders. FRONTIERS IN PSYCHIATRY 4.
Journal Article
273 (3), pp. 527 - 539 (2023)
Mapping Research Domain Criteria using a transdiagnostic mini-RDoC assessment in mental disorders: a confirmatory factor analysis. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 5.
Journal Article
14 (1), 55 (2022)
Effects of stressful life-events on DNA methylation in panic disorder and major depressive disorder. CLINICAL EPIGENETICS 6.
Journal Article
5 (9), e2230367 (2022)
Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression A Randomized Clinical Trial. JAMA NETWORK OPEN 7.
Journal Article
13, 937582 (2022)
Recurrent suicide attempts affect normalization of HPA axis dysregulation after recovery from major depression. FRONTIERS IN PSYCHIATRY 8.
Journal Article
91 (3), pp. 313 - 327 (2022)
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors. BIOLOGICAL PSYCHIATRY 9.
Journal Article
5 (1), 580 (2022)
Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals. COMMUNICATIONS BIOLOGY 10.
Journal Article
Identification of transdiagnostic psychiatric disorder subtypes using unsupervised learning. NEUROPSYCHOPHARMACOLOGY (2021)
11.
Journal Article
131, 105286 (2021)
Effects of weariness of life, suicide ideations and suicide attempt on HPA axis regulation in depression. PSYCHONEUROENDOCRINOLOGY 12.
Journal Article
26 (1), e12880 (2021)
Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. ADDICTION BIOLOGY 13.
Journal Article
67 (2), pp. 224 - 225 (2021)
Evidence for a prothrombotic State in Patients with remitted Depression. ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE 14.
Journal Article
25 (9), pp. 1236 - 1247 (2020)
Chronotype is associated with psychological well-being depending on the composition of the study sample. JOURNAL OF HEALTH PSYCHOLOGY 15.
Journal Article
10 (1), 210 (2020)
Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients. TRANSLATIONAL PSYCHIATRY 16.
Journal Article
87 (5), pp. 419 - 430 (2020)
Classical Human Leukocyte Antigen Alleles and C4 Haplotypes Are Not Significantly Associated With Depression. BIOLOGICAL PSYCHIATRY 17.
Journal Article
25 (7), pp. 1430 - 1446 (2020)
Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank. MOLECULAR PSYCHIATRY 18.
Journal Article
183 (6), pp. 309 - 330 (2020)
Genetic comorbidity between major depression and cardio-metabolic traits, stratified by age at onset of major depression. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 19.
Journal Article
31, p. S62 - S62 (2020)
Developing a digital decision support system for an early estimation of treatment response in depression. EUROPEAN NEUROPSYCHOPHARMACOLOGY 20.
Journal Article
21 (10), pp. 766 - 774 (2020)
Evidence for an enhanced procoagulant state in remitted major depression. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY